<?xml version="1.0" encoding="UTF-8"?>
<ref id="B111-plants-09-01784">
 <label>111.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rajappa</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Sireesh</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Salai</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Ramkumar</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Sarvajayakesavulu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Madhunapantula</surname>
    <given-names>S.V.</given-names>
   </name>
  </person-group>
  <article-title>Treatment with naringenin elevates the activity of transcription factor nrf2 to protect pancreatic Î²-cells from streptozotocin-induced diabetes in vitro and in vivo</article-title>
  <source>Front. Pharm.</source>
  <year>2019</year>
  <volume>9</volume>
  <fpage>1562</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2018.01562</pub-id>
 </element-citation>
</ref>
